U Leuschner
Overview
Explore the profile of U Leuschner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
164
Citations
591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Leuschner U
Praxis (Bern 1994)
. 2006 Oct;
95(40):1550-6.
PMID: 17048413
Since nowadays liver diseases are being diagnosed more frequently than in former years, an increasing number of patients with skeletal alterations is detected. Predominant is osteoporosis with the feared complications...
4.
Leuschner U, Manns M, Eisebitt R
Z Gastroenterol
. 2005 Sep;
43(9):1051-9.
PMID: 16142614
The effects in clinical studies of UDCA on the endpoints "death" or "pre-transplantation survival" can only be shown when UDCA therapy is started in an early disease phase, preferably in...
5.
Schlichting J, Leuschner U
J Cell Mol Med
. 2002 Jun;
5(1):98-115.
PMID: 12067457
No abstract available.
6.
Holtmeier J, Leuschner U
Digestion
. 2002 Jan;
64(3):137-50.
PMID: 11786661
Treatment of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) with ursodeoxycholic acid (UDCA) has been in common use since 1985. In PBC, treatment with UDCA improves laboratory data,...
7.
Hofmann M, Schumann C, Zimmer G, Henzel K, Locher U, Leuschner U
Chem Phys Lipids
. 2001 May;
110(2):165-71.
PMID: 11369325
Large unilamellar vesicles were prepared from phosphatidylcholine (PC), sphingomyelin (SM), cholesterol (Chol) and cardiolipin (CL) by an extrusion technique (LUVETs). Diffusion of the more hydrophobic lithocholic acid (LCA) and the...
8.
Leuschner U
Praxis (Bern 1994)
. 2000 Jul;
89(24):1043-8.
PMID: 10902460
Primary biliary cirrhosis is a cholestatic autoimmune disease of the liver. Its prevalence has significantly increased over the last seven years, therefore it can no longer be considered to be...
9.
Leuschner M, Dietrich C, You T, Seidl C, Raedle J, Herrmann G, et al.
Gut
. 1999 Dec;
46(1):121-6.
PMID: 10601067
Background: In some patients with primary biliary cirrhosis, ursodeoxycholic acid causes full biochemical normalisation of laboratory data; in others, indexes improve but do not become normal. Aims: To characterise complete...
10.
Leuschner M, Maier K, Schlichting J, Strahl S, Herrmann G, Dahm H, et al.
Gastroenterology
. 1999 Sep;
117(4):918-25.
PMID: 10500075
Background & Aims: Ursodeoxycholic acid (UDCA) is used for treatment of primary biliary cirrhosis. Previous studies showed that, compared with UDCA monotherapy, bile salts plus prednisolone had no further effect...